Filling in the Missing Letters

A new algorithm brings together data from second - and third - generation genome sequencers.

By | July 3, 2012

A new algorithm published yesterday (July 2) in Nature Biotechnology takes the best of second- and third-generation sequencing technologies to produce fuller and more accurate whole genome sequences.

Second-generation sequencers read short DNA snippets—between 100 and 700 base pairs long—then stitch them together to produce a full genome. However, stitching them in the correct order remains a challenge. Third-generation sequencers, on the other hand, can read long stretches of DNA at once, but are more prone to errors. The new algorithm, developed by researchers at the National Biodefense Analysis and Countermeasures Center in Frederick, Maryland, corrects the sequences obtained from third-generation sequencers using the short reads of their second-generation counterparts.

The researchers tested the new algorithm on the Escherichia coli and yeast genomes, and found it increased accuracy by up to 99.9 percent. The algorithm was also used to sequence the genome of the common pet parakeet (Melopsittacus undulates) for the first time.

This new approach may be useful for researchers interested in sequences that lie beyond gene-coding regions, Adam Phillippy, the bioinformatics researcher who led the study, told Nature. “Normally people just get the genes out, but you lose structural information,” he said.

For example, the algorithm may be particularly adept for transcriptome analysis, which could benefit from reads that scan an entire messenger RNA sequence, Elaine Mardis, co-director of the Genome Institute at Washington University in St Louis, Missouri, told Nature. (Read a profile on Elaine Mardis from The Scientist’s January 2012 issue).

Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo


Avatar of: Disgruntled


Posts: 1457

July 3, 2012

American scientists don't get paid what they deserve because foreigners are taking over the job market.

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham